Medistim ASA has transferred 10,000 shares to Medistim
CEO Kari Krogstad as part of her compensation for
2017. It is part of her agreement with the Board of
Medistim that she receives 10,000 shares if she is in
position as CEO until 1st of January 2017. The
agreement has been previously described in the
Company's Annual Report. Medistims last traded share
price in 2016 was 73.50 so the shares are transferred
at this cost. Medistim ASA has 186,000 own shares and a
after the transfer to Kari Krogstad the company has
176,000 own shares shares.
Krogstad agreement gives her additional 12,500 shares
in Medistim if she is in position by end 2017. This is
also described in the latest Annual Report. The Board
of Medistim ASA has decided to award Kari Krogstad
with another 10,000 shares if she is in position as
CEO by end 2018.
Kari Krogstad has after the latest transfer 100,000
shares in Medistim ASA.